IG VENA

This brand name is authorized in Austria, Hong Kong SAR China, Israel, Malta, Poland, Romania, Singapore, Tunisia.

Active ingredients

The drug IG VENA contains one active pharmaceutical ingredient (API):

1	Human plasma protein of which human immunoglobulins at least 95% UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)
	Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects.
	Read more about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	60992, 61005, 61006, 61007
IL	מִשְׂרַד הַבְּרִיאוּת	8652, 8653
MT	Medicines Authority	MA128/00301, MA128/00302, MA128/00303, MA128/00304
PL	Rejestru Produktów Leczniczych	100176888
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43962001, W43963001, W43964001, W43965001, W68982001, W68982002, W68982003
SG	Health Sciences Authority	14050P
TN	Direction de la Pharmacie et du Médicament	13043051H, 13043052H